OA12134A - Novel substituted pyrazoloÄ4-3-eÜdiazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them. - Google Patents
Novel substituted pyrazoloÄ4-3-eÜdiazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them. Download PDFInfo
- Publication number
- OA12134A OA12134A OA1200200203A OA1200200203A OA12134A OA 12134 A OA12134 A OA 12134A OA 1200200203 A OA1200200203 A OA 1200200203A OA 1200200203 A OA1200200203 A OA 1200200203A OA 12134 A OA12134 A OA 12134A
- Authority
- OA
- OAPI
- Prior art keywords
- diazepin
- pyrazolo
- dihydro
- ethyl
- ppm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0000095A FR2803299B1 (fr) | 2000-01-05 | 2000-01-05 | NOUVELLES PYRAZOLO [4,3-e] DIAZEPINES SUBSTITUEES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA12134A true OA12134A (en) | 2006-05-05 |
Family
ID=8845641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200200203A OA12134A (en) | 2000-01-05 | 2000-12-27 | Novel substituted pyrazoloÄ4-3-eÜdiazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them. |
Country Status (42)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1199074A1 (en) * | 2000-09-15 | 2002-04-24 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| EP1188438A1 (en) * | 2000-09-15 | 2002-03-20 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
| TW200745106A (en) * | 2005-10-03 | 2007-12-16 | Astrazeneca Ab | Chemical compounds |
| KR20160080799A (ko) | 2014-12-30 | 2016-07-08 | 한국해양과학기술원 | 금 촉매를 이용한 α-피론 유도체 전합성 방법 및 이에 의해 합성되어 인간 암세포주에 세포독성을 가지는 α-피론 유도체 |
| EP3551632B1 (en) | 2016-12-12 | 2024-06-12 | UNION therapeutics A/S | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors |
| US10906915B2 (en) | 2016-12-12 | 2021-02-02 | Leo Pharma A/S | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors |
| DK3551634T3 (da) | 2016-12-12 | 2021-06-14 | Union Therapeutics As | Substituerede pyrazoloazepin-8-oner og anvendelse deraf som phosphodiesterasehæmmere |
| TWI812739B (zh) * | 2018-06-21 | 2023-08-21 | 景凱生物科技股份有限公司 | Nadph氧化酶抑制劑、含其的醫藥組合物、及其應用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3764688A (en) * | 1972-07-27 | 1973-10-09 | Abbott Lab | 4,6-DIHYDRO-1,3-DIMETHYL-8-PHENYL-4-PROPARGYL-PYRAZOLO {8 4,3-e{9 {0 DIAZEPIN-5 (1H) ONE IN TREATING INFLAMMATION |
-
2000
- 2000-01-05 FR FR0000095A patent/FR2803299B1/fr not_active Expired - Fee Related
- 2000-12-23 DZ DZ000158A patent/DZ3103A1/xx active
- 2000-12-27 JP JP2001550229A patent/JP2003519233A/ja active Pending
- 2000-12-27 PL PL00356668A patent/PL356668A1/xx not_active Application Discontinuation
- 2000-12-27 TR TR2002/01719T patent/TR200201719T2/xx unknown
- 2000-12-27 EP EP00991657A patent/EP1248787B1/en not_active Expired - Lifetime
- 2000-12-27 AT AT00991657T patent/ATE278692T1/de not_active IP Right Cessation
- 2000-12-27 NZ NZ519520A patent/NZ519520A/en unknown
- 2000-12-27 OA OA1200200203A patent/OA12134A/en unknown
- 2000-12-27 SK SK940-2002A patent/SK9402002A3/sk unknown
- 2000-12-27 HU HU0204213A patent/HUP0204213A2/hu unknown
- 2000-12-27 EE EEP200200373A patent/EE200200373A/xx unknown
- 2000-12-27 CA CA002396315A patent/CA2396315A1/en not_active Abandoned
- 2000-12-27 CZ CZ20022222A patent/CZ20022222A3/cs unknown
- 2000-12-27 ES ES00991657T patent/ES2226978T3/es not_active Expired - Lifetime
- 2000-12-27 WO PCT/EP2000/013380 patent/WO2001049689A2/en active Search and Examination
- 2000-12-27 CN CN00818202A patent/CN1420888A/zh active Pending
- 2000-12-27 IL IL15039400A patent/IL150394A0/xx unknown
- 2000-12-27 EA EA200200610A patent/EA005071B1/ru not_active IP Right Cessation
- 2000-12-27 AP APAP/P/2002/002572A patent/AP2002002572A0/en unknown
- 2000-12-27 BR BR0016926-9A patent/BR0016926A/pt not_active Application Discontinuation
- 2000-12-27 AU AU33678/01A patent/AU3367801A/en not_active Abandoned
- 2000-12-27 KR KR1020027008692A patent/KR20020063293A/ko not_active Application Discontinuation
- 2000-12-27 MX MXPA02006618A patent/MXPA02006618A/es active IP Right Grant
- 2000-12-27 DE DE60014712T patent/DE60014712T2/de not_active Expired - Fee Related
-
2001
- 2001-01-03 AR ARP010100024A patent/AR032298A1/es not_active Application Discontinuation
- 2001-01-03 PE PE2001000003A patent/PE20011041A1/es not_active Application Discontinuation
- 2001-01-03 TN TNTNSN01001A patent/TNSN01001A1/fr unknown
- 2001-01-03 UY UY26517A patent/UY26517A1/es not_active Application Discontinuation
- 2001-01-03 PA PA20018509601A patent/PA8509601A1/es unknown
- 2001-01-04 SV SV2001000253A patent/SV2001000253A/es not_active Application Discontinuation
- 2001-01-04 HN HN2001000002A patent/HN2001000002A/es unknown
- 2001-01-04 CO CO01000514A patent/CO5290255A1/es not_active Application Discontinuation
- 2001-01-04 GT GT200100002A patent/GT200100002A/es unknown
-
2002
- 2002-06-19 IS IS6437A patent/IS6437A/is unknown
- 2002-07-01 CR CR6693A patent/CR6693A/es not_active Application Discontinuation
- 2002-07-02 BG BG106893A patent/BG106893A/xx unknown
- 2002-07-02 ZA ZA200205287A patent/ZA200205287B/en unknown
- 2002-07-03 MA MA26719A patent/MA26863A1/fr unknown
- 2002-07-04 NO NO20023249A patent/NO20023249L/no not_active Application Discontinuation
- 2002-07-05 HR HR20020577A patent/HRP20020577A2/hr not_active Application Discontinuation
-
2003
- 2003-03-24 HK HK03102129.7A patent/HK1050002A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7557110B2 (en) | Pyrazolo[1,5-A] pyrimidine derivatives | |
| US20110046127A1 (en) | Imidazopyridazines for Use as Protein Kinase Inhibitors | |
| EP2752415B1 (en) | Fluorinated ligands for targeting peripheral benzodiazepine receptors | |
| BRPI0622030A2 (pt) | Derivados de purina 7-substituída, para imunossupressão | |
| WO2009037394A2 (fr) | DERIVES DE 6-CYCLOAMINO-S-(PYRIDAZIN-YL)IMIDAZO[1,2-b]-PYRIDAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE. | |
| WO2009077956A2 (ru) | ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Нh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ | |
| JP2005502662A (ja) | ホスホジエステラーゼ阻害剤としての１−アルキルまたは１−シクロアルキルトリアゾロ［４，３−ａ］キナゾリン−５−オン類 | |
| CZ20032539A3 (en) | Imidazo-pyrimidine derivatives as ligands for gaba receptors | |
| BG106026A (bg) | 1-АМИНОТРИАЗОЛО/4,3-а/ХИНАЗОЛИН-5-ОНИ И/ИЛИ -5-ТИОНИ ИНХИБИРАЩИ ФОСФОДИЕСТЕРАЗА IV | |
| TWI222449B (en) | Triazolo-pyridazine derivatives as ligands for GABA receptors | |
| BRPI0612075A2 (pt) | pirazolo[1,5-a]pirimidinas halogenadas, processos, usos receptores gaba-a, composições e intermediários | |
| CA2602303A1 (en) | Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents | |
| OA12134A (en) | Novel substituted pyrazoloÄ4-3-eÜdiazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them. | |
| JP2013527226A (ja) | ３，４−ジヒドロピロロ［１，２−ａ］ピラジン−２，８（１Ｈ）−ジカルボキサミド誘導体、その調製、およびその治療的使用 | |
| CA2747365A1 (fr) | Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, leur preparation et leur application en therapeutique | |
| JP2006219373A (ja) | Ｐｄｅ７阻害作用を有するピリジニルピラゾロピリミジノン誘導体 | |
| CA2747359A1 (fr) | Derives de 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine et 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine, leur preparation et leur application en therapeutique | |
| WO2022127755A1 (en) | Compounds as casein kinase inhibitors | |
| US7232816B2 (en) | Substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medical products and processes for preparing them | |
| WO2006084835A1 (en) | N-(3-(imidazo [1,5-a]pyrimidin-4-yl)phenyl]-sulfonamides and n-[3-(imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-carboxamides and their use as gabaa receptor modulators |